Navigation Links
Video: Celebrities and Thousands of Walkers Unite at Nation's Capitol to Raise Awareness About Seizures and Epilepsy
Date:3/28/2009

WASHINGTON, March 28 /PRNewswire/ -- Thousands of epilepsy advocates, caregivers, patients and their families joined television stars and sports celebrities at the nation's Capitol today to support the third annual National Walk for Epilepsy. Over the past two years, the event has raised more than $2 million dollars and engaged more than 13,000 walkers. Today's event is expected to increase those numbers significantly. Money raised from the Walk helps create much needed programs for people with epilepsy and aid in the search for a cure. The National Walk for Epilepsy was hosted by the Epilepsy Foundation with financial support from Ortho-McNeil Neurologics(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/walkforepilepsy/36523/

Walk chair and star of NBC's "Heroes," Greg Grunberg, whose son has epilepsy, as well as New York Jets offensive lineman and eight-time Pro Bowler, Alan Faneca, and Atlanta Falcons running back Jason Snelling, both diagnosed years ago, all led their own teams of family, friends and fans. And Cincinnati Bengals cornerback, Geoffrey Pope, led his Gridiron Gang team for the second year in honor of his grandmother, who has epilepsy.

"The Walk has continued to gain momentum as more celebrities and people throughout the nation have helped make this the world's largest event dedicated to raising awareness and funds for epilepsy," said president and CEO of the Epilepsy Foundation, Eric Hargis. "This event has helped bring epilepsy to the forefront of discussions and gain national attention. We are grateful to the thousands of individuals who helped in our journey to educate, empower and encourage the epilepsy community."

"We were really proud to be part of the Walk again and bring our families and friends together to support the epilepsy community," said Faneca. "It provides a great opportunity to let other people with epilepsy know that they should be advocates for themselves, find the highest quality care and move forward with accomplishing their dreams."

For the first year, Walk participants had the opportunity to view exhibits on topics important to the epilepsy community through the "Educate, Empower and Encourage (E3) Exhibit" held on the National Mall following the Walk. Experts in neurology were stationed throughout the exhibit and addressed topics such as patient and physician communication, treatment options and other participant questions. Educational and inspirational messages and videos could also be viewed from a mini-theater helping people with epilepsy become better informed about living with the condition.

About Epilepsy

Epilepsy is a serious neurological condition that can develop at any time in life, but there is a particular susceptibility in young children and the elderly. The condition produces seizures, which can range from a momentary disruption of the senses, to short periods of unconsciousness or staring spells, to convulsions. A seizure happens when a brief, strong surge of electrical activity affects part or all of the brain. When a person has two or more unprovoked seizures, they are considered to have epilepsy. Currently there is no cure for epilepsy; however, more than half of people with epilepsy are able to control seizures with existing treatment options.

The Epilepsy Foundation

The Epilepsy Foundation, a national non-profit with affiliated organizations throughout the United States, has led the fight against epilepsy since 1968. The Foundation's goals are to ensure that people with seizures are able to participate in all life experiences; and to prevent, control and cure epilepsy through services, education, advocacy and research, so not another moment is lost to seizures. For additional information, please visit www.epilepsyfoundation.org.

Ortho-McNeil Neurologics(R)

Headquartered in Titusville, N.J., Ortho-McNeil Neurologics(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, focuses exclusively on providing solutions that improve neurological health. The company has products for Alzheimer's disease, epilepsy, and acute and preventive migraine treatment. Ortho-McNeil Neurologics(R), in conjunction with internal and external research partners, continues to explore new opportunities to develop solutions for unmet healthcare needs in neurology. For more information, visit www.OrthoMcNeilNeurologics.com.


'/>"/>
SOURCE Ortho-McNeil Neurologics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... Phytomer USA ... As a Phytomer Account Manager, Smith’s role is to provide excellent customer ... that make up The Phytomer Group. Smith comes to Phytomer with a wealth of ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of New Jersey ... “A” and its outlook as “stable.” At the same time, the ratings agency cautioned ... recent years, dip below “capital adequacy” thresholds required for its strong rating. , “Horizon ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... liability could substantially improve drug safety and minimize the cost of development. In ... ion channel inhibition using cell lines and for cardiac toxicity using induced pluripotent ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: